Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806695) titled 'Islet Function in Gestational Diabetes' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Mayo Clinic
Condition:
Gestational Diabetes Mellitus
Intervention:
Drug: Exendin 9-39
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 90
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07806695
Disclaimer: Curated by HT Syndication....